| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |